// App-Quantinova.ai

4223 : Combination Therapy with Novel Nanoparticle, SNS01-T, and Lenalidomide Triggers Synergistic Cytotoxicity in Vitro and in Vivo in Multiple Myeloma and Mantle Cell Lymphoma

Researchers

Presenter

  • Terence Tang

Principal Investigators

  • Zhongda Liu

  • Sarah Francis

  • Zheng Qifa

  • Richard Dondero

  • John Thompson

Medical Centers

  • University of Waterloo, Waterloo, ON, Canada

Locations

  • Canada

Companies

  • Senesco Technologies

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mantle cell lymphoma

  • Multiple Myeloma

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • SNS01

Outcome

  • N/A

Study Design

  • open label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved